ABSTRACT
BACKGROUND
Little is known about the contribution of patient behavior to incomplete laboratory monitoring, and the reasons for patient non-completion of ordered laboratory tests remain unclear.
OBJECTIVE
To describe factors, including patient-reported reasons, associated with non-completion of ordered laboratory tests.
DESIGN
Mixed-Methods study including a quantitative assessment of the frequency of patient completion of ordered monitoring tests combined with qualitative, semi-structured, patient interviews.
PARTICIPANTS
Quantitative assessment included patients 18 years or older from a large multispecialty group practice, who were prescribed a medication requiring monitoring. Qualitative interviews included a subset of show and no-show patients prescribed a cardiovascular, anticonvulsant, or thyroid replacement medication.
MAIN MEASURES
Proportion of recommended monitoring tests for each medication not completed, factors associated with patient non-completion, and patient-reported reasons for non-completion.
KEY RESULTS
Of 27,802 patients who were prescribed one of 34 medications, patient non-completion of ordered tests varied (range: 0–24 %, by drug-test pair). Factors associated with higher odds of test non-completion included: younger patient age (< 40 years vs. ≥ 80 years, adjusted odds ratio [AOR] 1.52, 95 % confidence interval [95 % CI] 1.27–1.83); lower medication burden (one medication vs. more than one drug, AOR for non-completion 1.26, 95 % CI 1.15–1.37), and lower visit frequency (0–5 visits/year vs. ≥ 19 visits/year, AOR 1.41, 95 % CI 1.25 to 1.59). Drug-test pairs with black box warning status were associated with greater odds of non-completion, compared to drugs without a black box warning or other guideline for testing (AOR 1.91, 95 % CI 1.66–2.19). Qualitative interviews, with 16 no-show and seven show patients, identified forgetting as the main cause of non-completion of ordered tests.
CONCLUSIONS
Patient non-completion contributed to missed opportunities to monitor medications, and was associated with younger patient age, lower medication burden and black box warning status. Interventions to improve laboratory monitoring should target patients as well as physicians.
Similar content being viewed by others
REFERENCES
Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64.
Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.
Raebel MA, Lyons EE, Andrade SE, et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005;20(12):1120–6.
Simon SR, Andrade SE, Ellis JL, et al. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc. 2005;53(12):2165–9.
Lo HG, Matheny ME, Seger DL, Bates DW, Gandhi TK. Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care. J Am Med Inform Assoc. 2009;16(1):66–71.
Steele AW, Eisert S, Witter J, et al. The effect of automated alerts on provider ordering behavior in an outpatient setting. PLoS Med. 2005;2(9):e255.
Feldstein AC, Smith DH, Perrin N, et al. Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med. 2006;166(17):1848–54.
Hoch I, Heymann AD, Kurman I, Valinsky LJ, Chodick G, Shalev V. Countrywide computer alerts to community physicians improve potassium testing in patients receiving diuretics. J Am Med Inform Assoc. 2003;10(6):541–6.
Matheny ME, Sequist TD, Seger AC, et al. A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc. 2008;15(4):424–9.
Palen TE, Raebel M, Lyons E, Magid DM. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. Am J Manag Care. 2006;12(7):389–95.
Raebel MA, Carroll NM, Andrade SE, et al. Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. 2006;12(5):268–74.
Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37(1):34–9.
Canizares MJ, Penneys NS. The incidence of nonattendance at an urgent care dermatology clinic. J Am Acad Dermatol. 2002;46(3):457–9.
Pal B, Taberner DA, Readman LP, Jones P. Why do outpatients fail to keep their clinic appointments? Results from a survey and recommended remedial actions. Int J Clin Pract. 1998;52(6):436–7.
Martin C, Perfect T, Mantle G. Non-attendance in primary care: the views of patients and practices on its causes, impact and solutions. Fam Pract. 2005;22(6):638–43.
Lacy NL, Paulman A, Reuter MD, Lovejoy B. Why we don’t come: patient perceptions on no-shows. Ann Fam Med. 2004;2(6):541–5.
Lash S, Harding J. “Abandoned prescriptions” a quantitative assessment of their cause. J Manag Care Pharm. 1995;1:193–9.
Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–43.
George A, Rubin G. Non-attendance in general practice: a systematic review and its implications for access to primary health care. Fam Pract. 2003;20(2):178–84.
Tjia J, Field TS, Garber LD, et al. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care. 2010;16(7):489–96.
Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–9. discussion 1081–1090.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res. 2010;10:140.
Wang LM, Wong M, Lightwood JM, Cheng CM. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother. 2010;44(1):28–34.
Rogers WH. Regression standard errors in clustered samples. Stata Tech Bull. 1993;13:19–23.
Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645–6.
Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge: MIT Press; 2002.
Froot KA. Consistent covariance matrix estimation with cross-sectional dependence and heteroskedasticity in financial data. J Financ Quant Anal. 1989;24:333–55.
Harrell FE. Regression Modeling Strategies: with Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer Verlag; 2001.
Oppenheim GL, Bergman JJ, English EC. Failed appointments: a review. J Fam Pract. 1979;8(4):789–96.
Rodriguez Pacheco R, Negro Alvarez JM, Campuzano Lopez FJ, et al. Non-compliance with appointments amongst patients attending an Allergology Clinic, after implementation of an improvement plan. Allergol Immunopathol (Madr). 2007;35(4):136–44.
Zailinawati AH, Ng CJ, Nik-Sherina H. Why do patients with chronic illnesses fail to keep their appointments? A telephone interview. Asia Pac J Public Health. 2006;18(1):10–5.
Simmons AV, Atkinson K, Atkinson P, Crosse B. Failure of patients to attend a medical outpatient clinic. J R Coll Physicians Lond. 1997;31(1):70–3.
Collins J, Santamaria N, Clayton L. Why outpatients fail to attend their scheduled appointments: a prospective comparison of differences between attenders and non-attenders. Aust Health Rev. 2003;26(1):52–63.
Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
Higginbottom GM. Sampling issues in qualitative research. Nurse Res. 2004;12(1):7–19.
Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522–5.
Glaser B, Strauss A. Grounded Theory: the Discovery of Grounded Theory. New York: de Gruyter; 1967.
Raebel MA, Lyons EE, Chester EA, et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Arch Intern Med. 2005;165(20):2395–401.
Tang PC, Ralston M, Arrigotti MF, Qureshi L, Graham J. Comparison of methodologies for calculating quality measures based on administrative data versus clinical data from an electronic health record system: implications for performance measures. J Am Med Inform Assoc. 2007;14(1):10–5.
Fischer SH, Tjia J, Field TS. Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: a systematic review. J Am Med Inform Assoc. 2010;17(6):631–6.
Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med. 2006;144(10):742–52.
McMahan R. Operationalizing MTM, through the use of health information technology. J Manag Care Pharm. 2008;14(2 Suppl):S18–21.
Black AD, Car J, Pagliari C, et al. The impact of eHealth on the quality and safety of health care: a systematic overview. PLoS Med. 2011;8(1):e1000387.
Tjia J, Field TS, Fischer SH, et al. Quality measurement of medication monitoring in the “meaningful use” era. Am J Manag Care. 2011;17(9):633–7.
Raebel MA, Carroll NM, Simon SR, et al. Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm. 2006;12(8):656–64.
Acknowledgements
Contributors
The authors would like to acknowledge the contributions of Yanfang Zhao, MA.
Funders
This study was funding by grant R18 HS 017906 from the Agency for Healthcare Research and Quality (AHRQ).
Prior Presentations
We presented the manuscript abstract at the Clinical and Translational Science Research Retreat at the University of Massachusetts Medical School on May 22, 2012 and the qualitative results only on May 20, 2011. We presented the results from the qualitative interviews at the HMO Research Network Conference in Boston, MA, on March 24, 2011. We presented a portion of the quantitative study findings as a poster at the AHRQ Health Information Technology conference on September 27, 2010.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fischer, S.H., Field, T.S., Gagne, S.J. et al. Patient Completion of Laboratory Tests to Monitor Medication Therapy: A Mixed-Methods Study. J GEN INTERN MED 28, 513–521 (2013). https://doi.org/10.1007/s11606-012-2271-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-012-2271-6